Risk Factors for Multidrug-Resistant Organisms Infection in Diabetic Foot Ulcer

References

• Zha ML, Cai JY, Chen HL. A bibliometric analysis of global research production pertaining to diabetic foot ulcers in the past ten years. J Foot Ankle Surg. 2019;58(2):253–259. doi:10.1053/j.jfas.2018.08.052
   PubMed Web of Science ®Google Scholar
• Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (dagger). Ann Med. 2017;49(2):106–116. doi:10.1080/07853890.2016.1231932
   PubMed Web of Science ®Google Scholar
• Fu XL, Ding H, Miao WW, Mao CX, Zhan MQ, Chen HL. Global recurrence rates in diabetic foot ulcers: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2019;35(6):e3160. doi:10.1002/dmrr.3160
   PubMed Web of Science ®Google Scholar
• Walsh JW, Hoffstad OJ, Sullivan MO, Margolis DJ. Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom. Diabet Med. 2016;33(11):1493–1498. doi:10.1111/dme.13054
   PubMed Web of Science ®Google Scholar
• Al-Rubeaan K, Almashouq MK, Youssef AM, et al. All-cause mortality among diabetic foot patients and related risk factors in Saudi Arabia. PLoS One. 2017;12(11):e0188097. doi:10.1371/journal.pone.0188097
   Web of Science ®Google Scholar
• Rastogi A, Goyal G, Kesavan R, et al. Long term outcomes after incident diabetic foot ulcer: multicenter large cohort prospective study (EDI-FOCUS investigators) epidemiology of diabetic foot complications study: epidemiology of diabetic foot complications study. Diabetes Res Clin Pract. 2020;162:108113. doi:10.1016/j.diabres.2020.108113
   PubMed Web of Science ®Google Scholar
• Gazzaruso C, Gallotti P, Pujia A, Montalcini T, Giustina A, Coppola A. Predictors of healing, ulcer recurrence and persistence, amputation and mortality in type 2 diabetic patients with diabetic foot: a 10-year retrospective cohort study. Endocrine. 2021;71(1):59–68. doi:10.1007/s12020-020-02431-0
   PubMed Web of Science ®Google Scholar
• Moulik PK, Mtonga R, Gill GV. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care. 2003;26(2):491–494. doi:10.2337/diacare.26.2.491
   PubMed Web of Science ®Google Scholar
• Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217–228. doi:10.1001/jama.293.2.217
   PubMed Web of Science ®Google Scholar
• Chen D, Wang M, Shang X, et al. Development and validation of an incidence risk prediction model for early foot ulcer in diabetes based on a high evidence systematic review and meta-analysis. Diabetes Res Clin Pract. 2021;180:109040. doi:10.1016/j.diabres.2021.109040
   Web of Science ®Google Scholar
• Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev. 2020;16(5):442–449. doi:10.2174/1573399815666191024085838
   PubMed Web of Science ®Google Scholar
• Rastogi A, Mukhopadhyay S, Sahoo JP, et al. Intensive glycemic control for diabetic foot ulcer healing: a multicentric, randomized, parallel arm, single-blind, controlled study protocol (INGLOBE study). Int J Low Extrem Wounds;2020. 1534734620952245. doi:10.1177/1534734620952245
   Web of Science ®Google Scholar
• Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response! Crit Care. 2013;17(2):305. doi:10.1186/cc12514
   PubMed Web of Science ®Google Scholar
• Tobalem M, Uckay I. Images in clinical medicine. Evolution of a diabetic foot infection. N Engl J Med. 2013;369(23):2252. doi:10.1056/NEJMicm1211053
   Web of Science ®Google Scholar
• Matta-Gutiérrez G, García-Morales E, García-álvarez Y, Álvaro-afonso FJ, Molines-Barroso RJ, Lázaro-Martínez JL. The influence of multidrug-resistant bacteria on clinical outcomes of diabetic foot ulcers: a systematic review. J Clin Med. 2021;10(9):1948. doi:10.3390/jcm10091948
   Web of Science ®Google Scholar
• Henig O, Pogue JM, Martin E, et al. The impact of multidrug-resistant organisms on outcomes in patients with diabetic foot infections. Open Forum Infect Dis. 2020;7(5):ofaa161. doi:10.1093/ofid/ofaa161
   Web of Science ®Google Scholar
• Saltoglu N, Surme S, Ezirmik E, et al. The effects of antimicrobial resistance and the compatibility of initial antibiotic treatment on clinical outcomes in patients with diabetic foot infection. Int J Low Extrem Wounds. 2021;15347346211004141. doi:10.1177/15347346211004141
   Web of Science ®Google Scholar
• Sannathimmappa MB, Nambiar V, Aravindakshan R, et al. Diabetic foot infections: profile and antibiotic susceptibility patterns of bacterial isolates in a tertiary care hospital of Oman. J Educ Health Promot. 2021;10:254. doi:10.4103/jehp.jehp_1552_20
   Google Scholar
• Mashaly M, Kheir MAE, Ibrahim M, Khafagy W. Aerobic bacteria isolated from diabetic foot ulcers of Egyptian patients: types, antibiotic susceptibility pattern and risk factors associated with multidrug-resistant organisms. Germs. 2021;11(4):570–582. doi:10.18683/germs.2021.1292
   PubMedGoogle Scholar
• Yan X, Song JF, Zhang L, Li X. Analysis of risk factors for multidrug-resistant organisms in diabetic foot infection. BMC Endocr Disord. 2022;22(1):46. doi:10.1186/s12902-022-00957-0
   Web of Science ®Google Scholar
• Rastogi A, Sukumar S, Hajela A, et al. The microbiology of diabetic foot infections in patients recently treated with antibiotic therapy: a prospective study from India. J Diabetes Complications. 2017;31(2):407–412. doi:10.1016/j.jdiacomp.2016.11.001
   Web of Science ®Google Scholar
• Monteiro-Soares M, Russell D, Boyko EJ, et al. Guidelines on the classification of diabetic foot ulcers (IWGDF 2019). Diabetes Metab Res Rev. 2020;36(Suppl 1):e3273.
   PubMedGoogle Scholar
• Lipsky BA, Berendt AR, Cornia PB, et al. 2012 infectious diseases society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):e132–173. doi:10.1093/cid/cis346
   PubMed Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Ji X, Jin P, Chu Y, Feng S, Wang P. Clinical characteristics and risk factors of diabetic foot ulcer with multidrug-resistant organism infection. Int J Low Extrem Wounds. 2014;13(1):64–71. doi:10.1177/1534734614521236
   Web of Science ®Google Scholar
• Neubeiser A, Bonsignore M, Tafelski S, et al. Mortality attributable to hospital acquired infections with multidrug-resistant bacteria in a large group of German hospitals. J Infect Public Health. 2020;13(2):204–210. doi:10.1016/j.jiph.2019.07.025
   Web of Science ®Google Scholar
• Barrasa-Villar JI, Aibar-Remón C, Prieto-Andrés P, Mareca-Doñate R, Moliner-Lahoz J. Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms. Clin Infect Dis. 2017;65(4):644–652. doi:10.1093/cid/cix411
   PubMed Web of Science ®Google Scholar
• Zimny S, Schatz H, Pfohl M. The effects of ulcer size on the wound radius reductions and healing times in neuropathic diabetic foot ulcers. Exp Clin Endocrinol Diabetes. 2004;112(4):191–194. doi:10.1055/s-2004-817932
   Web of Science ®Google Scholar
• Oyibo SO, Jude EB, Tarawneh I, et al. The effects of ulcer size and site, patient’s age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med. 2001;18(2):133–138. doi:10.1046/j.1464-5491.2001.00422.x
   PubMed Web of Science ®Google Scholar
• Thorud JC, Plemmons B, Buckley CJ, Shibuya N, Jupiter DC. Mortality after nontraumatic major amputation among patients with diabetes and peripheral vascular disease: a systematic review. J Foot Ankle Surg. 2016;55(3):591–599. doi:10.1053/j.jfas.2016.01.012
   PubMed Web of Science ®Google Scholar
• Cascini S, Agabiti N, Davoli M, et al. Survival and factors predicting mortality after major and minor lower-extremity amputations among patients with diabetes: a population-based study using health information systems. BMJ Open Diabetes Res Care. 2020;8(1):e001355. doi:10.1136/bmjdrc-2020-001355
   Web of Science ®Google Scholar
• Hoffstad O, Mitra N, Walsh J, Margolis DJ. Diabetes, lower-extremity amputation, and death. Diabetes Care. 2015;38(10):1852–1857. doi:10.2337/dc15-0536
   PubMed Web of Science ®Google Scholar
• Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. doi:10.3389/fimmu.2018.00754
   PubMed Web of Science ®Google Scholar
• Avan A, Tavakoly Sany SB, Ghayour-Mobarhan M, Rahimi HR, Tajfard M, Ferns G. Serum C-reactive protein in the prediction of cardiovascular diseases: overview of the latest clinical studies and public health practice. J Cell Physiol. 2018;233(11):8508–8525. doi:10.1002/jcp.26791
   PubMed Web of Science ®Google Scholar
• Huang Y, Cao Y, Zou M, et al. A comparison of tissue versus swab culturing of infected diabetic foot wounds. Int J Endocrinol. 2016;2016:8198714. doi:10.1155/2016/8198714
   PubMed Web of Science ®Google Scholar
• Andrianaki AM, Koutserimpas C, Kafetzakis A, et al. Diabetic foot infection and osteomyelitis. Are deep-tissue cultures necessary? Germs. 2020;10(4):346–355. doi:10.18683/germs.2020.1227
   Google Scholar